Following tumor establishment, anti-FOLR1 CAR T cells were intravenously injected at a single dose (1 × 107 CAR T cells, 85% transduction efficacy, Supplementary Figure S7a), and mice were monitored over a period of 21 d, including weekly blood withdrawals (Figure 3a). The gene discussed is FOLR1; the disease is neoplasm.